Calumet Specialty Products Partners (NASDAQ: CLMT) reported Q3 EPS of $0.86, $0.41 better than the analyst estimate of $0.45. Revenue for the quarter came in at $1.14 billion versus the consensus estimate of $1.11 billion.

Financial Guidance

Updated 2015 Capital Spending Forecast. For the full year 2015, the Partnership anticipates total capital expenditures of approximately $370 million, an increase from the prior guidance of $320 million to $335 million.

Reiterate 2015 RFS Compliance Guidance. In conjunction with the Partnership's ongoing compliance with the U.S. Renewable Fuels Standard ("RFS"), Calumet expects to purchase blending credits referred to as Renewable Identifications Numbers ("RINs"). The Partnership records its outstanding RINs obligation as a balance sheet liability. This liability is marked-to-market on a quarterly basis to reflect the market price of RINs on the last day of each quarter. The Partnership expects its gross estimated annual RINs obligation, which includes RINs that are required to be secured through either blending or through the purchase of RINs in the open market, will be in the range of 90 million to 100 million RINs for the full year 2015, excluding the provision for any hardship waivers that may or may not be granted by the U.S. Environmental Protection Agency to any of the Partnership's fuel refineries.

For earnings history and earnings-related data on Calumet Specialty Products Partners (CLMT) click here.